Question 1

What is CordenPharma?

Accepted Answer

CordenPharma is a Entity.

Question 2

How often does CordenPharma appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was CordenPharma first tracked by Ergen?

Accepted Answer

First tracked on May 27, 2026.

Question 4

When was CordenPharma last mentioned in news?

Accepted Answer

Last active on May 27, 2026.

Question 5

What is CordenPharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is CordenPharma in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving CordenPharma?

Accepted Answer

CordenPharma acquires AmbioPharm (May 27, 2026, 7 articles).

Question 8

How did the "CordenPharma acquires AmbioPharm" event impact CordenPharma?

Accepted Answer

CordenPharma is acquiring AmbioPharm to expand its global peptide API development and manufacturing capabilities, strengthening its position as a leading CDMO partner.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.